June 2019: Quanta to Exhibit at the 56th Annual ERA-EDTA Congress

Quanta Dialysis Technologies, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that the Company will be exhibiting at the 56th Annual European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday 13th to Sunday 16th June, at the Hungexpo in Budapest, Hungary, at booth number 1.040.

Click Here To Read The Full Press Release


April 2019: Results From SC+ Human Factors Testing Published In Hemodialysis International

Quanta Dialysis Technologies, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that results from its human factors testing (HFT) of SC+ have been published in Hemodialysis International, a leading peer-reviewed journal for the renal community. SC+ was designed to empower patients to take control of their lives by making selfcare and home haemodialysis more accessible through a device that is small, simple to use, and powerful enough to deliver dialysis adequacy. This addresses the need for a dialysis system that is appealing to patients while also being suitable for use across the continuum of care, from the clinic to the home.

Click Here To Read The Full Press Release


March 2019: Quanta To Present At The 39th Annual Dialysis Conference

Quanta Dialysis Technologies, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that the Company will be presenting at the 39th Annual Dialysis Conference (ADC), which runs from 16 to 19 March 2019, at the Sheraton Dallas Hotel, Texas, USA. Dr. Paul Komenda, Chief Medical Officer, will provide an update on SC+, explaining how it enables choice, efficiency and empowerment to both patients and physicians in the "Home Dialysis Machines" session on Monday, 18 March at 3:00pm. The presentation will be followed by a device demonstration at 3:45pm.

Click Here To Read The Full Press Release


February 2019: Quanta Strengthens Management Team In Preparation For Launch of SC+

Quanta Dialysis Technologies, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces the expansion of its management team with the appointment of Steve Lane as Commercial Director, Chanel Allen-Megahey as Global Quality Assurance and Regulatory Affairs Director and Frank Herrmann as Marketing Director.

Click Here To Read The Full Press Release


January 2019: Quanta Appoints Dr. Paul Komenda As New Chief Medical Officer

Quanta Dialysis Technologies, today announces that the Company has appointed Dr. Paul Komenda as Chief Medical Officer. Dr. Komenda, Associate Professor of Medicine at the University of Manitoba, is a fellow of the American Society of Nephrology and has extensive clinical and academic experience. Dr. Komenda previously served on the Scientific Advisory Board of NxStage Medical. He gained his medical qualification in 2001 from the University of Manitoba and is a board certified Nephrologist. Dr. Komenda studied health economics at the University of Calgary, holds a Masters in Health Administration and is also the Medical Director of the Home Dialysis Program and the Seven Oaks General Hospital in Manitoba.

Click Here To Read The Full Press Release


October 2018: Quanta Wins Industrial Product Design of the Year at the Plastics Industry Awards 2018

Quanta Dialysis Technologies, today announces that the Company has won the "Industrial Product Design of the Year" award at the Plastics Industry Awards 2018. The design of the SC+ haemodialysis system focuses on providing an intuitive user experience, centring on a large, interactive graphical touchscreen that guides users through a treatment via logical steps. This intuitive, tablet-style approach, combined with ergonomic industrial design, is intended to provide patients with a simple yet powerful platform for managing their treatments around their lives. Furthermore, every detail of the user experience and product design is streamlined to provide maximum safety and ease of use. The small footprint and modern design of the SC+ machine blends unobtrusively into different environments, expanding the range of treatment options available to patients.

Click Here To Read The Full Press Release


August 2018: Quanta To Exhibit At The 11th UK Annual Dialysis Conference

Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 11th UK Annual Dialysis Conference, taking place from Thursday 20th to Friday 21st September, at the Lowry Hotel in Manchester, UK. The UK Annual Dialysis Conference theme for 2018 is 'Advancing Dialysis: Now and for the Future' and will focus on clinical challenges, innovative solutions and future advances in dialysis care. Quanta will exhibit the new look of its personal haemodialysis system, SC+, which it plans to launch in 2019. SC+ is designed to give patients flexibility and to empower them to take control of their dialysis, enabling them to fit treatment around everyday life.

Click Here To Read The Full Press Release


May 2018: Quanta To Exhibit At The 55th Annual ERA-EDTA Congress

Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 55th Annual European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday 24th to Sunday 27th May, at the Bella Center in Copenhagen, Denmark at booth number 4.151. Quanta will be showcasing its new look, state-of-the-art personal haemodialysis system, SC+, designed to offer patients flexibility enabling them to fit treatment around everyday life.

Click Here To Read The Full Press Release


April 2018: Quanta Successfully Completes Pilot Treatments in France

Quanta Dialysis Technologies, today announces that the Company has successfully completed a clinical pilot to treat patients in France. Building off its successful UK pilot, this is the first time Quanta's personal haemodialysis system, SC+ has been used outside the UK. The treatments took place over a two-week period with five patients in Hôpital Necker, Paris. The treatments were led by French nurses who were trained by Quanta. These initial treatments in France were in addition to the ongoing pilot study in the UK, which has so far resulted in more than 1,400 successful patient treatments.

Click Here To Read The Full Press Release


March 2018: Quanta To Present At The 38th Annual Dialysis Conference

Quanta Dialysis Technologies, today announces that the Company will be presenting at the 38th Annual Dialysis Conference (ADC), which runs from 3 to 6 March 2018 at the Marriott Orlando World Center in Florida, USA. Peter Hoyer, Chief Commercial Officer, will provide an update on Quanta's unique small, simple and powerful haemodialysis system, SC+, in the 'Home HD Machines' session chaired by Robert Lockridge, MD, on Sunday 4 March at 2:15pm. The session will include an update on the results of the SC+ Pilot Study, which includes extensive, successful, patient treatments at four NHS Trusts across the UK.

Click Here To Read The Full Press Release


View our current Events

Quanta Dialysis Technologies, Self-Care+, SelfCareplus, SC+, Travel dialysis machine